Answers are grounded in this paper and cite their sources.
Shows the necessity of DPYD testing to prevent severe toxicity in patients, suggesting improved patient safety in healthcare systems.
genotyping as a patient-safety imperative necessary to achieve safer, more equitable fluoropyrimidine therapy worldwide.
No takes yet. Share an insight, caveat, or question.
Kratz et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: